To explore the underlying molecular mechanism of YBX1 interaction with G3BP1 in RCC progression, we investigated the effects of G3BP1 on the oncogenic signaling pathways that can be affected by YBX1 silencing. This evidence concerns the gene YBX1 and renal cell carcinoma.